Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sara N Ortwein Insider Profile
4 Followers
Sara N Ortwein, Exec. Officer at Exxon Mobil, holds 17.52K shares in Sanara MedTech (Ticker: SMTI), holds 363.58K shares in Exxon Mobil (Ticker: XOM).
Sara N Ortwein has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Sara N Ortwein holds in companies
Most Profitable Insider Trade
The most profitable trade made by Sara N Ortwein
Sara N Ortwein's Trading History
Exxon Mobil
Nov 30, 2018
Exec. Officer
Uninformative Buy
―
$43.75M
Sanara MedTech
Jun 14, 2024
Director
Uninformative Buy
―
$653.22K
List of latest transactions for each holding click on a transaction to see Sara N Ortwein's performance on stock
You May Also Like
Sara N Ortwein insider profile FAQ
What is the percentage of profitable transactions made by Sara N Ortwein?
The percentage of profitable transactions made by Sara N Ortwein is ―.
What is the average return per transaction made by Sara N Ortwein?
The average return per transaction made by Sara N Ortwein is ―.
What stocks does Sara N Ortwein hold?
Sara N Ortwein holds: XOM, SMTI stocks.
What was Sara N Ortwein’s latest transaction?
Sara N Ortwein latest transaction was an Uninformative Buy of ―.
What was Sara N Ortwein's most profitable transaction?
Sara N Ortwein’s most profitable transaction was an Informative Sell of XOM stock on December 19, 2016. The return on the trade was 5.30%.
What is Sara N Ortwein's role in Exxon Mobil?
Sara N Ortwein's role in Exxon Mobil is Exec. Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.